In particular, we observed a significant increase of CD44+ iMSC within the CD271+/CD73+ stromal compartment in MDS, harboring spliceosome mutations (Fig. 3H, I, and Supplementary Fig. 6B–D). The gene discussed is CD44; the disease is myelodysplastic syndrome.